About Bristol-Myers Squibb Company
Bristol-Myers Squibb (NYSE:BMY) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. It operates in various therapeutic areas, including oncology, cardiovascular, immunology, and fibrotic diseases. With a mission to transform patients' lives through science, Bristol-Myers Squibb is committed to advancing its pipeline through a combination of organic growth, collaborations, and strategic acquisitions. The company is recognized for its leading-edge research that aims to address some of the most challenging unmet medical needs. Through rigorous science, comprehensive clinical trial programs, and a patient-centric approach, Bristol-Myers Squibb strives to achieve superior outcomes and improve the health standards of communities worldwide.
Snapshot
Operations
Products and/or services of Bristol-Myers Squibb Company
- Revolutionizing cancer treatments, the immunotherapy Opdivo battles advanced lung and skin malignancies.
- Eliquis, a leading anticoagulant, significantly reduces the risk of stroke in patients with atrial fibrillation.
- Used in combination therapy, Yervoy boosts the body's immune system to combat melanoma.
- Sprycel, engineered to target specific leukemias, offers a lifeline to those with drug-resistant diseases.
- Rheumatoid arthritis sufferers benefit from Orencia, an immunosuppressant that mitigates symptoms and slows progression.
- Plavix, a blood thinner, prevents unfortunate recurrent heart attack or stroke events.